A mycotoxin sampling plan is defined by the mycotoxin test procedure (sample size, sample preparation method, and analytical method) and the accept/reject limit.
These criteria include, e.g., reporting of elicitation procedure, sample size, anchor states, and others.
The studies' relevance to human biology was unclear and details concerning the randomization procedure, sample size calculation, and husbandry conditions were often missing.
In addition to adverse events, we registered the study design, mode of reporting (that is, per patient or per procedure), sample size, period of adverse events collection, types of adverse events, and number of adverse events.
Variation in reported results can also stem from methodological reasons, such as differences in sampling procedure, in sample size and hence statistical power or in the variables considered in the statistical analysis.
With the new procedures, both sample size and sample error can be reduced.
The second limitation of this study arises from its sampling procedures and sample size.
Future studies should consider including representative samples of locations selected using standard statistical sampling procedures and sample size computations.
This pilot trial also refined the procedures and sample size requirements for a fully powered RCT.
Some participants declined one or more of the screening procedures; therefore, sample size is reported for each analysis presented in the Tables.
